US Broker Ratings

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with Nearly 97% Potential Upside

Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approaches to treating neurodegenerative diseases. Based in Dublin,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Biotechnology Innovator with 81.55% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, has been catching the eye of investors with its ambitious approach to treating central..

Abivax SA (ABVX) Stock Analysis: What Investors Should Know About Its 52-Week High and Analyst Consensus

Abivax SA (ABVX) has captured the attention of investors with a remarkable ascent to its current price of $133.09, marking the peak of its 52-week range,..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges with a 7.74% Potential Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a prominent player in the biotechnology sector, specializing in cell programming. Despite its innovative approach and diversified services across..

EyePoint Pharmaceuticals (EYPT) Stock Analysis: A 120.5% Upside Potential Amidst Clinical Developments

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biotechnology company dedicated to advancing treatments for serious retinal diseases, presents a captivating opportunity for investors, particularly given the company’s..

Celcuity Inc. (CELC) Stock Analysis: Exploring the 5.63% Potential Upside in Biotech Innovation

Celcuity Inc. (CELC), a promising player in the biotechnology sector, is catching the attention of investors following its recent surge in market activity. With a market..

Standard BioTools Inc. (LAB) Investor Outlook: Navigating Volatility in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB) presents an intriguing case for investors interested in the healthcare sector, specifically within medical devices. Headquartered in South San Francisco, California,..

Surmodics, Inc. (SRDX): Investor Outlook on Performance Amidst Challenges in Healthcare Sector

Surmodics, Inc. (NASDAQ: SRDX) is a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Eden Prairie, Minnesota, the company focuses..

MeiraGTx Holdings plc (MGTX) Investor Outlook: Exploring a 215% Potential Upside in the Biotech Sector

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its potential for significant upside, as suggested by a 215% increase in target price...

Bioventus Inc. (BVS) Stock Analysis: A 102% Potential Upside in the Medical Devices Sector

Bioventus Inc. (BVS), a notable player in the healthcare sector, provides innovative medical devices aimed at relieving pain and addressing musculoskeletal therapies. With a market capitalization..

Dianthus Therapeutics (DNTH) Stock Analysis: A Biotech Gem with 51.45% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the eye of investors in the healthcare sector, particularly those with an interest in biotechnology. Founded in 2019 and..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Challenging Landscape with Strategic Collaborations and Growth Potential

Personalis, Inc. (PSNL), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, offers a suite of cutting-edge cancer genomic tests and..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a 12,113% Revenue Surge and 11.60% Upside Potential

Septerna, Inc. (SEPN) is capturing the attention of investors in the biotechnology sector with its remarkable 12,113.10% revenue growth and a potential 11.60% upside, according to..

Altimmune, Inc. (ALT) Investor Outlook: Exploring a Potential 234% Upside

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, has captured investor interest with its ambitious pipeline and substantial potential upside. Specializing in treatments for obesity, metabolic, and..

Atai Beckley N.V. (ATAI): Investor Outlook with a 171% Potential Upside and Robust Revenue Growth

Atai Beckley N.V. (NASDAQ: ATAI) emerges as a compelling investment opportunity within the biotechnology sector, particularly for investors keen on the burgeoning field of mental health..

Zenas BioPharma, Inc. (ZBIO) Investor Outlook: Strong Buy Ratings Signal Potential 11.91% Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making significant waves in the biotechnology sector, particularly for investors seeking exposure to transformative immunology-based therapies. With an impressive market..

Kamada Ltd. (KMDA) Stock Analysis: A Potential 117% Upside for Savvy Healthcare Investors

Kamada Ltd. (NASDAQ: KMDA), a specialized player in the healthcare sector, has been garnering attention in the investment community, particularly due to its significant potential upside..

COMPASS Pathways Plc (CMPS) Stock Analysis: A Bold Bet on Mental Health with 142% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering entity in the mental health sector, is drawing attention as a high-risk, high-reward investment opportunity. With a market capitalization..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech Gem with a 115% Potential Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors in the healthcare sector with its innovative approach to combating cancer resistance mechanisms. As a..

PureTech Health plc (PRTC) Stock Analysis: Unpacking the 542.70% Revenue Growth in Biotechnology

PureTech Health plc (NASDAQ: PRTC), a prominent player in the biotechnology industry, is making waves with its staggering 542.70% revenue growth, a figure that has undoubtedly..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds